Intracranial Neoplasms and Paraneoplastic Disorders, Gliomatosis Cerebri
Adams & Victors Principles of Neurology, Chp 31, pg 654, Ropper, A.H.,et al, 2014
Intracranial Neoplasms and Paraneoplastic Disorders, Oligodendroglioma
Adams & Victors Principles of Neurology, Chp 31, pg 654, Ropper, A.H.,et al, 2014
Intracranial Neoplasms and Paraneoplastic Disorders, Ependymoma
Adams & Victors Principles of Neurology, Chp 31, pg 655, Ropper, A.H.,et al, 2014
Intracranial Neoplasms and Paraneoplastic Disorders, Meningioma
Adams & Victors Principles of Neurology, Chp 31, pg 656, Ropper, A.H.,et al, 2014
Intracranial Neoplasms and Paraneoplastic Disorders, Primary Central Nervous System Lymphoma
Adams & Victors Principles of Neurology, Chp 31, pg 658, Ropper, A.H.,et al, 2014
Intracranial Neoplasms and Paraneoplastic Disorders, Intracranial Metastatic Carcinoma
Adams & Victors Principles of Neurology, Chp 31, pg 659, Ropper, A.H.,et al, 2014
Intracranial Neoplasms and Paraneoplastic Disorders, Carcinomatous Meningitis
Adams & Victors Principles of Neurology, Chp 31, pg 662, Ropper, A.H.,et al, 2014
Intracranial Neoplasms and Paraneoplastic Disorders, Intravascular Lymphoma
Adams & Victors Principles of Neurology, Chp 31, pg 663, Ropper, A.H.,et al, 2014
Intracranial Neoplasms and Paraneoplastic Disorders, Hemangioblastoma of the Cerebellum
Adams & Victors Principles of Neurology, Chp 31, pg 668, Ropper, A.H.,et al, 2014
Predominant Intraventricular Hemorrhage From a Ruptured Posterior Communicating Artery Aneurysm
Neurohosp 4:164, Nakagawa, K. & Lee, S.B, 2014
The Acquired Metabolic Disorders of the Nervous System, Hashimoto Encephalopathy (Steroid Responsive Encephalopathy Syndrome)
Adams & Victors Principles of Neurology Chp 40, pg 1155, Ropper, A.H.,et al, 2014
Disorders of the Nervous System Caused by Drugs, Toxins, and Chemical Agents, Amphetamines and Related Agents
Adams & Victors Principles of Neurology Chp 43, pg 1213, Ropper, A.H.,et al, 2014
Disorders of the Nervous System Caused by Drugs, Toxins, and Chemical Agents, Cocaine
Adams & Victors Principles of Neurology Chp 43, pg 1213, Ropper, A.H.,et al, 2014
Disorders of the Nervous System Caused by Drugs, Toxins, and Chemical Agents, Lead
Adams & Victors Principles of Neurology Chp 43, pg 1220, Ropper, A.H.,et al, 2014
Degenerative Diseases of the Nervous System, Alzheimer Disease
Adams & Victors Principles of Neurology, Chp 39, pg 1063, Ropper, A.H.,et al, 2014
Degenerative Diseases of the Nervous System, Parkinson Disease
Adams & Victors Principles of Neurology, Chp 39, pg 1082, Ropper, A.H.,et al, 2014
Degenerative Diseases of the Nervous System, Amyotrophic Lateral Sclerosis
Adams & Victors Principles of Neurology, Chp 39, pg 1109, Ropper, A.H.,et al, 2014
West Nile Virus: Review of the Literature
JAMA 310:308-315,267, Petersen, L.R.,et al, 2013
Faxtor Xa Inhibitors Versus Vitamin K Antagonists for Preventing Cerebral or Systemic Embolism in Patients with Atrial Fibrillation
Stroke 44:e165-e167, Bruins, K.M.H., & Berge, E., 2013
Evaluation of Patients for Paroxysmal Atrial Fibrillation after Ischemic Stroke
Stroke 44:e168-e170, Sundararajan, K.,et al, 2013
Thrombolysis for Acute Ischemic Stroke in Patients with Cancer
Stroke 44:3573-3576, Murthy, S.B.,et al, 2013
Glycosylated Hemoglobin A1 Predicts Risk for Symptomatic Hemorrhage After Thrombolysis for Acute Stroke
Stroke 44:2134-2138, Rocco, A.,et al, 2013
Prospective, Multicenter, Single-Arm Study of Mechanical Thrombectomy Using Solitaire Flow Restoration in Acute Ischemic Stroke
Stroke 44:2802-2807, Pereira, V.,et al, 2013
Thrombolysis for Ischemic Stroke Associated with Infective Endocarditis
Stroke 44:2917-2919, Asaithambi, G.,et al, 2013
Safety of Intravenous Thrombolysis for Ischemic Stroke in Patients Treated with Warfarin
Ann Neurol 74:266-274, Mazya, M.V.,et al, 2013
Bilateral Cerebellar Hemorrhage in Vermian Vein Thrombosis
Neurol 81:1364-1365, Lattanzi, S., et al, 2013
Encephalitis and GABAb Receptor Antibodies
Neurol 81:1500-1506, H�ftberger, R.,et al, 2013
Fungal Infections Associated with Contaminated Methylprednisolone Injections
NEJM 369:1598-1609, Smith, R.M.,et al, 2013
Clinical Findings for Fungal Injections Caused by Methylprednisolone Injections
NEJM 369:1610-1619, Chiller, T.M.,et al, 2013
Serum Creatinine May Indicate Risk of Symptomatic Intracranial Hemorrhage after Intravenous Tissue Plasminogen Activator (IV tPA)
Medicine 92:317-323, Marsh, E.B.,et al, 2013
Primary Leptomeningeal Lymphoma
Neurol 81:1690-1696, Taylor, J.W.,et al, 2013
IV Thrombolysis and Renal Function
Neurol 81:1780-1788, Gensicke, H.,et al, 2013
An Index to Identify Stroke-Related vs Incidental Patent Foramen Ovale in Cryptogenic Stroke
Neurol 81:619-625,619, Kent, D.M.,et al, 2013
Patent Foramen Ovale and Cryptogenic Stroke
Stroke 44:2676-2678, Furlan, A.J. and Jauss, M., 2013
A 35-Year-Old Woman with Acute Seizures and Behavior Change
Neurol 81:e55-e59, Rejeski, J.J.,et al, 2013
Reversible Cerebral Vasoconstriction Syndrome and Cervical Artery Dissection in 20 Patients
Neurol 81:821-824, Mawet, J.,et al, 2013
Frequency and Characteristics of Isolated Psychiatric Episodes in Anti-N-Methyl-D-Aspartate Receptor Encephalitis
JAMA Neurol 70:1133-1139, Kayser, M.S.,et al, 2013
Interdependence and Contributions of Sun Exposure and Vitamin D to MRI Measures in Multiple Sclerosis
JNNP 84:1075-1081, 1066, Zivadinov, R.,et al, 2013
Thrombolysis of Basilar Artery Occlusion: Impact of Baseline Ischemia and Time
Ann Neurol 73:688-694, Strbian, D.,et al, 2013
Early Surgery Versus Initial Conservative Treatment in Patients with Spontaneous Lobar Intracerebral Haemotomas (STICH II): a Randomized Trial
Lancet 382:397-408,377, Mendelow, A.D.,et al, 2013
Surgery or Conservative Therapy for Cerebral Hemorrhage?
Lancet 382:377-378, Gautschi, O.P. & Schaller, K., 2013
Atypical Imaging Features of Epstein-Barr Virus-Positive Primary Central Nervous System Lymphomas in Patients without AIDS
AJNR 34:1562-1567, Lee, H.Y.,et al, 2013
TREM2 Variants in Alzheimers Disease
NEJM 368:117-127, Guerreiro, R.,et al, 2013
Variant of TREM2 Associated with the Risk of Alzheimers Disease
NEJM 368:107-116, Jonsson, T.,et al, 2013
Variant TREM2 as Risk Factor for Alzheimers Disease
NEJM 368:182-184, Neumann, H. & Daly, M., 2013
Clinicopathologic Conference, Rabies Encephalitis
NEJM 368:172-180, Case 1-2013, 2013
Efficacy and Safety of Everolimus for Subependymal Giant Cell Astrocytomas Associated with Tuberous Sclerosis Complex (EXIST-1): A Multicenter, Randomized, Placebo-Controlled Phase 3 Trial
Lancet 381:125-132, Franz, D.,et al, 2013
A 62-Yeal-Old Man with Fluctuating Neurological Deficits and Skin Lesions
JAMA Neurol 70:120-124, Konikkara, J.,et al, 2013
Clinicopathologic Conference, Cholesteatoma & Cholesterol Granuloma with Chronic Otitis Media, with Dural SinusThrombosis
NEJM 368:267-277, Case 2-2013, 2013
Everolimus Long-Term Safety and Efficacy in Subependymal Giant Cell Astrocytoma
Neurol 80:574-580, Krueger, D.,et al, 2013